New Study Reveals Potential for Radical New Treatment of Paralysisand Brain Disease

U.S. NewswireJuly 25, 2005

Linked as:

Summary


HELSINKI, Finland, July 25 /U.S. Newswire/ -- A study released today could reveal the key to treating nearly 140 million people worldwide who suffer from spinal cord injuries, Alzheimer's disease, ALS and other devastating neurological diseases.

The study, published in the online version of the Journal of Neuroscience Research, shows how a protein called KDI tri-peptide (KDI) can block the harmful effects of a substance called glutamate that is present in all degenerative brain diseases and spinal cord injuries, causing permanent cell death and preventing the repair of damaged nerve connections. Glutamate is produced as part of the body's natural reaction to central nervous system damage.

See the full content of this document

Extract


New Study Reveals Potential for Radical New Treatment of Paralysisand Brain Disease

In the new study, researchers at the Brain Laboratory at the University of Helsinki -- http://www.brainlab.fi -- and at the Johnnie B. Byrd Sr., Alzheimer's Center & Research Institute in Tampa, Fla., show KDI to be a potent and wide-ranging b...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company